The human prostate cancer cell line PC-3 and the human breast cancer cell lines MDA-MB-231 and MDA-MB-453 are widely used by research groups working with bombesin, as they are reported to express GRP-R [24,25,26,27,30,32,36,41,53,54,55]. Here, GRPR is linked to prostate carcinoma.